DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bits-pilani.ac.in:8080/jspui/xmlui/handle/123456789/13741
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSinghvi, Gautam-
dc.date.accessioned2024-01-09T07:13:30Z-
dc.date.available2024-01-09T07:13:30Z-
dc.date.issued2022-04-
dc.identifier.urihttps://www.tandfonline.com/doi/full/10.1080/17425247.2022.2053674-
dc.identifier.urihttp://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/13741-
dc.description.abstractThe current drug therapies for treating rheumatoid arthritis (RA) include nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, or biological products designed to mitigate the symptoms of the disease. These therapies with conventional delivery systems possess limitations such as lack of selectivity and adverse effects in the extra-articular tissues. Microneedles-based transdermal drug delivery gained huge attention that can overcome the limitations associated with conventional preparations.en_US
dc.language.isoenen_US
dc.publisherTaylor & Francisen_US
dc.subjectPharmacyen_US
dc.subjectMicroneedlesen_US
dc.subjectRheumatoid arthritisen_US
dc.subjectSkin layersen_US
dc.subjectTransdermal deliveryen_US
dc.subjectPainen_US
dc.titleEmerging trends in microneedle-based drug delivery strategies for the treatment of rheumatoid arthritisen_US
dc.typeArticleen_US
Appears in Collections:Department of Pharmacy

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.